ERASCA INC. Share Price Today: Live Updates & Key Insights
ERASCA INC. share price today is $19.49, up -1.19%. The stock opened at $19.37 against the previous close of $19.34, with an intraday high of $19.815 and low of $19.09.
ERASCA INC. Share Price Chart
ERASCA INC.
ERASCA INC. Share Price Performance
ERASCA INC. Institutional Holdings
ERASCA INC. Market Status
ERASCA INC. Fundamentals
Market Cap 6713.44 M
PB Ratio 17.0861
PE Ratio 0.0
Enterprise Value 5816.61 M
Total Assets 396.15 M
Volume 3176641
ERASCA INC. Company Financials
About ERASCA INC. & investment objective
Company Information Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes ERAS-0015, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors; ERAS-4001, a pan-KRAS inhibitor for the treatment of patients with KRAS-mutated solid tumors; and ERAS-12, an investigational EGFR D2/D3 biparatopic antibody (bpAb) for the treatment of EGFR and RAS/MAPK solid tumors. It has license agreement with Guangzhou Joyo Pharmatech Co., Ltd to develop, manufacture, and commercialize certain pan-RAS inhibitors; Medshine Discovery Inc. to develop, manufacture, and commercialize certain pan-KRAS inhibitors; Novartis Pharma AG to develop, manufacture, use, and commercialize naporafenib; NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds; and Asana BioSciences, LLC to develop and commercialize ERAS-007 and certain other related compounds. The company has a clinical trial collaboration and supply agreement with Tango Therapeutics, Inc. for the evaluation of ERAS-0015. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 103
Industry Biotechnology
CEO Dr. Jonathan E. Lim M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
ERASCA INC. FAQs
What is the share price of ERASCA INC. today?
The current share price of ERASCA INC. is $19.49.
Can I buy ERASCA INC. shares in India?
Yes, Indian investors can buy ERASCA INC. shares by opening an international trading and demat account with Motilal Oswal.
How to buy ERASCA INC. shares in India?
You can easily invest in ERASCA INC. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy ERASCA INC. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of ERASCA INC..
Can I buy fractional shares of ERASCA INC.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of ERASCA INC.?
ERASCA INC. has a market cap of $6713.44 M.
In which sector does ERASCA INC. belong?
ERASCA INC. operates in the Biotechnology sector.
What documents are required to invest in ERASCA INC. stocks?
To invest, you typically need:
What is the PE and PB ratio of ERASCA INC.?
The PE ratio of ERASCA INC. is N/A and the PB ratio is 17.09.